Author/Creator: Noble, Carl W. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Noble, Carl W.

1. INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS: Ten-Year Follow-Up. Issue 8 (August 2022)

Authors:: Dudenhoefer, Nicholas E.; Noble, Carl W.; Petersen, Michael R.; Foster, Robert E.; Riemann, Christopher D.; Sisk, Robert A.; Hutchins, Robert K.; Miller, Daniel M.
Journal:: Retina
Issue:: Volume 42:Issue 8(2022)
Page Start:: 1568
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. INTRAVITREAL ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR FOR THE TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO OCULAR HISTOPLASMOSIS: Ten-Year Follow-Up. Issue 8 (August 2022)

Authors:: Dudenhoefer, Nicholas E.; Noble, Carl W.; Petersen, Michael R.; Foster, Robert E.; Riemann, Christopher D.; Sisk, Robert A.; Hutchins, Robert K.; Miller, Daniel M.
Journal:: Retina
Issue:: Volume 42:Issue 8(2022)
Page Start:: 1568
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Ocular Adverse Events following Use of Immune Checkpoint Inhibitors for Metastatic Malignancies. (17th August 2020)

Authors:: Noble, Carl W.; Gangaputra, Sapna S.; Thompson, Ian A.; Yuan, Amy; Apolo, Andrea B.; Lee, Jung-Min; Papaliodis, George N.; Kodati, Shilpa; Bishop, Rachel; Magone, M. Teresa; Sobrin, Lucia; Sen, H. Nida
Journal:: Ocular immunology and inflammation
Issue:: Volume 28:Number 6(2020)
Page Start:: 854
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗